• Markets
    • icon
  • Companies
IBX · ASX

Imagion Biosystems Ltd. (ASX:IBX)

AU$0.35

 0.01 (2.941%)
ASX:Live
30/11/2023 04:10:33 PM
HALO Ords GROWTH AUS Big Candle (Realtime) All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

IBX Overview

IBX Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About IBX

Website

Imagion Biosystems Ltd.

Telephone

N/A

Address

Level 25 525 Collins Street Melbourne, Victoria (VIC) 3000

Description

N/A

IBX Price Chart

Key Stats

Market Cap

n/a

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.3 - 1.44

Trade Value (12mth)

AU$14,295.00

1 week

7.94%

1 month

-22.73%

YTD

-64.58%

1 year

-67.92%

All time high

9

Key Fundamentals

EPS 3 yr Growth

-8.300%

EBITDA Margin

%

Operating Cashflow

-$8m

Free Cash Flow Return

-74.80%

ROIC

-90.90%

Interest Coverage

-63.80

Quick Ratio

2.90

Other Data

Shares on Issue (Fully Dilluted)

28m

HALO Sector

Healthcare

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

IBX Announcements

Latest Announcements

Date Announcements

31 October 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

31 October 22

Notification regarding unquoted securities - IBX

×

Notification regarding unquoted securities - IBX

31 October 22

Change of Registry Address

×

Change of Registry Address

31 May 23

Notification regarding unquoted securities - IBX

×

Notification regarding unquoted securities - IBX

31 May 23

Cleansing Statement under Section 708A(12C)(e)

×

Cleansing Statement under Section 708A(12C)(e)

31 May 19

Chairman's Address to Shareholders at Annual General Meeting

×

Chairman's Address to Shareholders at Annual General Meeting

31 May 19

Results of Annual General Meeting

×

Results of Annual General Meeting

31 May 18

Chairman's Address to Shareholders at Annual General Meeting

×

Chairman's Address to Shareholders at Annual General Meeting

31 May 18

Investor Presentation

×

Investor Presentation

31 May 18

Results of Annual General Meeting

×

Results of Annual General Meeting

31 July 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

31 July 23

Letter to Shareholders from the CEO, Dr. Isaac Bright

×

Letter to Shareholders from the CEO, Dr. Isaac Bright

30 January 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

30 August 23

Appendix 4D

×

Appendix 4D

30 August 23

Half-Year Financial Report

×

Half-Year Financial Report

30 August 23

Half-Year Results Release

×

Half-Year Results Release

30 April 20

Annual Report to shareholders

×

Annual Report to shareholders

30 April 19

Annual Report to shareholders

×

Annual Report to shareholders

29 May 23

Cancel - Notification regarding unquoted securities - IBX

×

Cancel - Notification regarding unquoted securities - IBX

29 July 22

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

28 September 22

Prostate cancer research update

×

Prostate cancer research update

28 October 22

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

28 October 19

Investor Presentation

×

Investor Presentation

28 May 21

AGM presentation

×

AGM presentation

28 May 21

Results of Annual General Meeting

×

Results of Annual General Meeting

28 March 23

Notice to IBXOA Option Holders

×

Notice to IBXOA Option Holders

28 June 23

Expanded collaboration with Siemens Healthineers to US

×

Expanded collaboration with Siemens Healthineers to US

28 January 22

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

IBX Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 25.0 19.4 -51.7 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.00 -0.00 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 39.7 -4.2 -57.2 Lock Lock Lock
     Yield % Lock Lock Lock Lock -4.3 -6.6 -31.9 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.01 0.01 0.00 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.01 0.01 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 132.4 -8.3 -64.8 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 747 1,048 1,121 Lock Lock Lock
Basic m Lock Lock Lock Lock 747 1,048 1,121 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -49.9 13.2 103.3 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 8 8 12 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -7 -8 -11 Lock Lock Lock
     Growth % Lock Lock Lock Lock -38.7 -11.4 -35.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -3,592.1 -3,535.6 -2,349.0 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -8 -9 -12 Lock Lock Lock
     Growth % Lock Lock Lock Lock -41.7 -11.5 -41.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -3,767.4 -3,709.3 -2,583.1 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -8 -9 -12 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -2 -3 -3 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -5 -6 -10 Lock Lock Lock
     Growth % Lock Lock Lock Lock -56.3 -12.3 -62.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2,607.5 -2,587.2 -2,071.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -5 -5 -8 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 15 5 -1 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -5 -5 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock -10.1 -14.2 -62.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -22.5 -22.7 -18.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 13 13 4 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 14 14 10 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 4 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -13 -13 0 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 1 1 5 Lock Lock Lock
Equity $m Lock Lock Lock Lock 13 13 5 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 13 13 8 Lock Lock Lock
     Growth % Lock Lock Lock Lock 268.3 0.9 -38.2 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -38.0 -42.7 -98.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -41.5 -45.3 -209.7 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -89.0 -64.2 -108.1 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -63.8 -45.4 -90.9 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -55.0 -38.2 -74.8 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Leverage
Interest Cover X Lock Lock Lock Lock -168.5 -1,052.8 -63.8 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.7 1.6 -0.0 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -97.1 -100.3 3.4 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 14.9 17.7 2.9 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 14.9 17.7 2.9 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 98.3 97.3 89.1 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -513.2 -653.2 -465.9 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 6.3 3.8 5.6 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.1 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 140.1 183.9 68.7 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -3,674.7 -3,709.0 -2,599.8 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -53.5 -61.2 -123.4 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -38.0 -42.7 -98.3 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.1 2.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -41.5 -45.3 -209.7 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -41.5 -45.3 -209.7 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 58.2 96.2 65.7 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 58.2 96.2 65.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 58.2 96.2 65.7 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

IBX Shortsell

Frequently Asked Questions

The current share price of Imagion Biosystems Ltd. (IBX:ASX) is AU$0.35.
The 52-week high share price for Imagion Biosystems Ltd. (IBX:ASX) is AU$1.44.
The 52-week low share price for Imagion Biosystems Ltd. (IBX:ASX)? is AU$0.30.
Imagion Biosystems Ltd. (IBX:ASX) does not pay a dividend.
Imagion Biosystems Ltd. (IBX:ASX) does not pay a dividend.
Imagion Biosystems Ltd. (IBX:ASX) does not offer franking credits.
Imagion Biosystems Ltd. (IBX:ASX) is classified in the Healthcare.
The current P/E ratio for Imagion Biosystems Ltd. (IBX:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.